... et al. v. MERCK & CO., case number 2:10-cv-04374, from Pennsylvania Eastern Court. ... UNITED STATES OF AMERICA et al. v. MERCK ... Merck & Co Inc.
Apr 26, 2018 ... The jury ruled for Merck but the district court ruled for Gilead, finding pre-litigation business misconduct and litigation misconduct attributable to ...
Sep 5, 2014 ... For the reasons that follow, Defendant's Motions regarding all claims for both .... Corp. v. Southmost Mach. Corp., 742 F.2d 786, 791 (3d Cir.1984). ..... and FDA regulations, 21 U.S.C. § 301 et seq. ; 42 U.S.C § 262 et seq. ; 21 ...
Apr 25, 2018 ... for Hepatitis C. Merck & Co., Inc. and Ionis Pharmaceu- ... Gilead Scis., Inc. v. ..... Inc. v. Merck & Co., Inc., et al., Case No. 5:13-cv-04057-. 5.
Merits Briefs. Brief for Petitioner Merck & Co. Joint Appendix Volume I · Brief for Respondent Richard Reynolds, et al. Reply Brief for Petitioner Merck & Co.
Apr 26, 2017 ... Eszopiclone (Lunesta®, Sunovion Pharmaceuticals Inc., Marlborough, MA, ... and elevation of orexin levels in the cerebrospinal fluid (CSF) (Estabrooke et al. ... and were approved by the Merck Animal Care and Use Committee. .... The effects of DORA‐22 versus eszopiclone on the regulation of histamine ...